Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is China National Accord Medicines OCF Yield %?
China National Accord MedicinesSZSE:000028 -1.00%57 OCF Yield % is 0.92 as of Sep. 15, 2026, which is 92% below its 10-year median of 10.85. GuruFocus rates SZSE:000028 with a GF Score™ of 57/100. The stock has 6 warning signs investors should review. Among 122 Medical Distribution companies, China National Accord Medicines ranks worse than 65.57% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for China National Accord Medicines's OCF Yield % or its related term are showing as below:
SZSE:000028'
s OCF Yield % Range Over the Past 10 Years
Min: 0.81 Med: 10.85 Max: 22.91
Current: 0.92
During the past 13 years, the highest OCF Yield % of China National Accord Medicines was 22.91%. The lowest was 0.81%. And the median was 10.85%.
SZSE:000028's OCF Yield % is ranked worse than 65.57% of 122
companies
in the Medical Distribution industry
Industry Median: 4.585
vs SZSE:000028: 0.92
China National Accord Medicines OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
China National Accord Medicines OCF Yield % Related Terms
China National Accord Medicines OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:000028 vs MCK, COR, CAH: OCF Yield % Comparison
For the Medical Distribution subindustry, China National Accord Medicines's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China National Accord Medicines OCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's OCF Yield % distribution charts can be found below:
* The bar in red indicates where China National Accord Medicines's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Accord Medicines (SZSE:000028) has a OCF Yield % of 0.92 as of Sep. 15, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on China National Accord Medicines and its competitors. This is 92% below median its historical median of 10.85. Over the past decade, China National Accord Medicines' OCF Yield % has ranged from 0.81 to 22.91. According to the industry distribution chart, China National Accord Medicines ranks #80 out of 122 companies in the Medical Distribution industry, placing it in the top 65.6%.
Is China National Accord Medicines' OCF Yield % too high?
China National Accord Medicines' current OCF Yield % of 0.92 is 92% below median its 10-year median of 10.85. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 22.91. The Medical Distribution industry median OCF Yield % is 4.59. China National Accord Medicines' value of 0.92 is 79.9% below this industry median. Based on the distribution chart, China National Accord Medicines ranks #80 out of 122 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, China National Accord Medicines has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does China National Accord Medicines' OCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China National Accord Medicines ranks #80 out of 122 companies for OCF Yield %. This places China National Accord Medicines in the lower half of its industry. The industry median OCF Yield % is 4.59. China National Accord Medicines' value of 0.92 is 79.9% below this benchmark. Historically, China National Accord Medicines' own OCF Yield % has ranged from 0.81 to 22.91 over the past decade. While the company's 10-year median is 10.85 vs. the industry median of 4.59, China National Accord Medicines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Distribution company?
The median OCF Yield % among Medical Distribution companies is 4.59, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China National Accord Medicines's current OCF Yield % of 0.92 is 79.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on China National Accord Medicines and its competitors. For the Medical Distribution industry, the median OCF Yield % is 4.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China National Accord Medicines's current OCF Yield % is 0.92, which is 92% below median its own 10-year median of 10.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Accord Medicines stock overvalued right now?
China National Accord Medicines (SZSE:000028) has a current OCF Yield % of 0.92. The current OCF Yield % is 0.92, which is 92% below median its 10-year median of 10.85 and 79.9% below the Medical Distribution industry median of 4.59. China National Accord Medicines' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For China National Accord Medicines (SZSE:000028), the current OCF Yield % is 0.92 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
57GF Score
Get the complete analysis for SZSE:000028
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000028 has been successfully added to your 
